For outsourcing facilities under section 503B compounding, distributing or dispensing tirzepatide injections within 90 calendar days from todays announcement, until March 19, 2025
Theres no benefit to pushing through severe symptoms
The taper is a tool for psychological and behavioral preparation, not a biological necessity
Officials at Novo Nordisk have announced that an oral tablet version of the GLP-1 drug became available on May 4 for adults diagnosed with type 2 diabetes
The review further distinguishes between established outcome benefits (CVD, CKD, and OSA) and conditions still under investigation (neurodegeneration, arthritis, and some liver endpoints)
ScienceDirect, 2026 #Ophthalmology #RetinalResearch #Biologics #3Rs To view or add a comment, sign in The "Animal-First" era of drug development just hit a massive turning point